• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.伴有高级别转化的鼻窦涎腺型分泌癌:关于这个未被充分认识的诊断实体及其预后和治疗意义的病例报告
Head Neck Pathol. 2018 Jun;12(2):274-278. doi: 10.1007/s12105-017-0855-5. Epub 2017 Oct 4.
2
ETV6 Gene Rearrangements Characterize a Morphologically Distinct Subset of Sinonasal Low-grade Non-intestinal-type Adenocarcinoma: A Novel Translocation-associated Carcinoma Restricted to the Sinonasal Tract.ETV6基因重排特征性地表现为鼻窦低度非肠型腺癌的一个形态学独特亚组:一种局限于鼻窦道的新型易位相关癌。
Am J Surg Pathol. 2017 Nov;41(11):1552-1560. doi: 10.1097/PAS.0000000000000912.
3
Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.鼻腔和咽腔分泌性癌:4 例回顾性分析及文献复习。
Ann Diagn Pathol. 2022 Dec;61:152052. doi: 10.1016/j.anndiagpath.2022.152052. Epub 2022 Oct 8.
4
High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.伴有 ETV6::NTRK3 融合的高级别非肠道型鼻窦腺癌,通过免疫表型和形态学与分泌性癌不同。
Virchows Arch. 2023 Aug;483(2):187-195. doi: 10.1007/s00428-023-03587-6. Epub 2023 Jul 6.
5
Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.涎腺乳腺样分泌性癌的特征:通过ETV6-NTRK3易位的存在及新的替代标志物与相似肿瘤相鉴别
Hum Pathol. 2015 Jan;46(1):94-103. doi: 10.1016/j.humpath.2014.09.012. Epub 2014 Oct 7.
6
Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.硬腭发生的具有高级别组织学特征的涎腺乳腺样分泌癌:1例报告并文献复习
Int J Clin Exp Pathol. 2014 Dec 1;7(12):9008-22. eCollection 2014.
7
Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.唾液腺乳腺样分泌性癌伴高级别转化:3 例 ETV6-NTRK3 基因融合病例报告及 TP53、β-catenin、EGFR 和 CCND1 基因分析。
Am J Surg Pathol. 2014 Jan;38(1):23-33. doi: 10.1097/PAS.0000000000000088.
8
Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.分泌型癌病例的临床病理研究,包括使用恩曲替尼治疗高级别转化的成功治疗结果:一例报告。
BMC Med Genomics. 2022 Jan 6;15(1):6. doi: 10.1186/s12920-022-01155-6.
9
A Pediatric Case of High-Grade Secretory Carcinoma of the Maxillary Sinus With Gene Fusion, Therapeutic Implications, and Review of the Literature.上颌窦高级别分泌型癌 1 例:基因融合、治疗意义及文献复习
Pediatr Dev Pathol. 2023 Jan-Feb;26(1):59-64. doi: 10.1177/10935266221138706. Epub 2022 Nov 30.
10
Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.Pan-Trk 免疫组化是诊断唾液腺癌和检测 ETV6-NTRK3 融合的一种敏感且特异的辅助工具。
Histopathology. 2020 Feb;76(3):375-382. doi: 10.1111/his.13981. Epub 2019 Dec 11.

引用本文的文献

1
Clinicopathologic characterization of secretory carcinoma of salivary gland.涎腺分泌型癌的临床病理特征。
World J Surg Oncol. 2024 Oct 25;22(1):282. doi: 10.1186/s12957-024-03561-9.
2
Translocations and Gene Fusions in Sinonasal Malignancies.鼻窦恶性肿瘤中的易位和基因融合。
Curr Oncol Rep. 2023 Apr;25(4):269-278. doi: 10.1007/s11912-023-01364-x. Epub 2023 Feb 8.
3
A Pediatric Case of High-Grade Secretory Carcinoma of the Maxillary Sinus With Gene Fusion, Therapeutic Implications, and Review of the Literature.上颌窦高级别分泌型癌 1 例:基因融合、治疗意义及文献复习
Pediatr Dev Pathol. 2023 Jan-Feb;26(1):59-64. doi: 10.1177/10935266221138706. Epub 2022 Nov 30.
4
Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.唾液腺癌:90 例多机构临床病理研究,重点是分级和预后因素。
Histopathology. 2022 Nov;81(5):670-679. doi: 10.1111/his.14772. Epub 2022 Sep 5.
5
Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract.原发及继发/转移性涎腺癌累及鼻腔鼻窦。
Head Neck Pathol. 2021 Sep;15(3):769-779. doi: 10.1007/s12105-020-01271-8. Epub 2021 Jan 11.
6
Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.免疫组织化学在鉴别唾液腺分泌性癌和涎腺闰管细胞癌中的作用。
Med Mol Morphol. 2021 Mar;54(1):23-30. doi: 10.1007/s00795-020-00256-4. Epub 2020 Jun 1.
7
Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer.TrkC信号在癌症致瘤性和转移调控中的作用。
Cancers (Basel). 2020 Jan 8;12(1):147. doi: 10.3390/cancers12010147.
8
(Mammary Analogue) Secretory Carcinoma of the Nasal Cavity: Report of a Rare Case with p63 and DOG1 Expression and Uncommon Exon 4-Exon 14 ETV6-NTRK3 Fusion Diagnosed with Next Generation Sequencing.(乳腺样)鼻腔分泌性癌:p63 和 DOG1 表达及罕见的外显子 4-外显子 14 ETV6-NTRK3 融合的罕见病例报告,该融合通过下一代测序诊断。
Head Neck Pathol. 2020 Jun;14(2):542-549. doi: 10.1007/s12105-019-01051-z. Epub 2019 Jul 4.

本文引用的文献

1
ETV6 Gene Rearrangements Characterize a Morphologically Distinct Subset of Sinonasal Low-grade Non-intestinal-type Adenocarcinoma: A Novel Translocation-associated Carcinoma Restricted to the Sinonasal Tract.ETV6基因重排特征性地表现为鼻窦低度非肠型腺癌的一个形态学独特亚组:一种局限于鼻窦道的新型易位相关癌。
Am J Surg Pathol. 2017 Nov;41(11):1552-1560. doi: 10.1097/PAS.0000000000000912.
2
Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.伴有高级别转化、CDKN2A/B缺失、远处转移且对克唑替尼缺乏持续反应的涎腺分泌性癌
Int J Surg Pathol. 2017 Oct;25(7):613-618. doi: 10.1177/1066896917709350. Epub 2017 May 12.
3
Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.采用原肌球蛋白相关激酶抑制剂LOXO-101成功治疗的伴有NTRK3-ETV6融合的婴儿纤维肉瘤
Pediatr Blood Cancer. 2016 Aug;63(8):1468-70. doi: 10.1002/pbc.26026. Epub 2016 Apr 19.
4
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.恩曲替尼,一种泛TRK、ROS1和ALK抑制剂,对多种分子定义的癌症适应症具有活性。
Mol Cancer Ther. 2016 Apr;15(4):628-39. doi: 10.1158/1535-7163.MCT-15-0758. Epub 2016 Mar 3.
5
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).乳腺类似物分泌癌(MASC)中ETV6-NTRK3基因被鉴定后,MASC背后隐藏着什么:恩曲替尼的临床反应和获得性耐药。
Ann Oncol. 2016 May;27(5):920-6. doi: 10.1093/annonc/mdw042. Epub 2016 Feb 15.
6
Sinonasal Adenocarcinoma: Update on Classification, Immunophenotype and Molecular Features.鼻窦腺癌:分类、免疫表型及分子特征的最新进展
Head Neck Pathol. 2016 Mar;10(1):68-74. doi: 10.1007/s12105-016-0694-9. Epub 2016 Feb 1.
7
Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.涎腺乳腺样分泌性癌:25例ETV6基因重排肿瘤的分子分析,标准逆转录聚合酶链反应未检测到经典ETV6-NTRK3融合转录本:4例携带ETV6-X基因融合病例报告
Am J Surg Pathol. 2016 Jan;40(1):3-13. doi: 10.1097/PAS.0000000000000537.
8
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.恩曲替尼:一种强效的新型TRK、ROS1和ALK抑制剂。
Expert Opin Investig Drugs. 2015;24(11):1493-500. doi: 10.1517/13543784.2015.1096344. Epub 2015 Oct 12.
9
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.一名软组织肉瘤患者中存在致癌性NTRK融合,对原肌球蛋白相关激酶抑制剂LOXO-101有反应。
Cancer Discov. 2015 Oct;5(10):1049-57. doi: 10.1158/2159-8290.CD-15-0443. Epub 2015 Jul 27.
10
Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.乳腺类似物分泌性癌、低级别涎腺导管癌及模仿者:一项对比研究。
Mod Pathol. 2015 Aug;28(8):1084-100. doi: 10.1038/modpathol.2015.64. Epub 2015 Jun 19.

伴有高级别转化的鼻窦涎腺型分泌癌:关于这个未被充分认识的诊断实体及其预后和治疗意义的病例报告

Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.

作者信息

Xu Bin, Aryeequaye Ruth, Wang Lu, Katabi Nora

机构信息

Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

出版信息

Head Neck Pathol. 2018 Jun;12(2):274-278. doi: 10.1007/s12105-017-0855-5. Epub 2017 Oct 4.

DOI:10.1007/s12105-017-0855-5
PMID:28980201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5953877/
Abstract

Secretory carcinoma (SC) is a recently described salivary gland carcinoma with characteristic ETV6-NTRK3 fusion. In this case report, we described a SC of the maxillary sinus that underwent high grade transformation in a 61-year-old patient. The diagnosis was confirmed by the presence of ETV6 translocation. Within the sinonasal tract, SC is an important differential diagnosis especially of sinonasal adenocarcinoma, non-intestinal type (non-ITAC), as these two entities bears histologic and immunophenotypic similarity. Distinction between these two tumors can be challenging based on the morphology alone and may require additional immunohistochemical and molecular studies. It is important to recognize that SC can occur in the sinonasal tract as correctly diagnosing SC may be prognostic relevant and may provide new targeted therapeutic avenues for these patients.

摘要

分泌性癌(SC)是一种最近才被描述的涎腺癌,具有特征性的ETV6-NTRK3融合基因。在本病例报告中,我们描述了一名61岁患者上颌窦的分泌性癌发生了高级别转化。通过检测到ETV6易位确诊。在鼻窦道内,分泌性癌是一个重要的鉴别诊断对象,尤其是与鼻窦腺癌、非肠型(非ITAC)的鉴别,因为这两种实体在组织学和免疫表型上具有相似性。仅根据形态学区分这两种肿瘤可能具有挑战性,可能需要额外的免疫组化和分子研究。认识到分泌性癌可发生于鼻窦道很重要,因为正确诊断分泌性癌可能与预后相关,并可能为这些患者提供新的靶向治疗途径。